Completed PHASE4 INTERVENTIONAL NCT00211744

Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

Sponsor: Montefiore Medical Center

Conditions Obsessive-compulsive Disorder

Interventions topiramate

Updated 5 times since 2017 Last updated: May 25, 2018 Started: Aug 31, 2004 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Obsessive-compulsive Disorder, this trial is completed. The trial is conducted by Montefiore Medical Center and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Montefiore Medical Center
Ortho-McNeil Pharmaceutical

Data source: Montefiore Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States